bcl-2 protects HL-60 cells from apoptosis by stabilizing their intracellular calcium pools

Life Sci. 2001 May 11;68(25):2873-83. doi: 10.1016/s0024-3205(01)01073-6.

Abstract

bcl-2 has been shown to enhance cell survival by inhibiting apoptosis induced under different circumstances. In this study we investigated the effects of bcl-2 overexpression on the homeostasis of subcellular organelles such as ER and mitochondria. In our study, HL-60/bcl-2 and control HL-60/neo cells were obtained by transfection of bcl-2 cDNA or the neomycin-resistant gene, respectively. Apoptosis was evaluated by both DNA fragmentation and flow cytometry qualitatively and quantitatively, and the intracellular calcium by Fura-2/AM. Thapsigargin (TG), a highly specific inhibitor of the ER-associated Ca2+ pump, and Br-A23187, a calcium ionophore, were used in this study. Our results showed that overexpression of bcl-2 significantly blocked TG- and Br-A23187-induced apoptosis in calcium containing buffer. Measurement of intracellular calcium showed that bcl-2 overexpression could reduce sustained elevation of cytosolic Ca2+ induced by these agents. However, in calcium-free medium, bcl-2 overexpression maintained Ca2+ uptake in ER of both TG- and Br-A23187-treated cells. Moreover, the depletion of Ca2+ by EGTA enhanced TG- and Br-A23187-induced apoptosis, and reduced the anti-apoptotic action of bcl-2, suggesting that cytosolic Ca2+ elevation may be required for optimal ER pool refilling. These findings suggest that bcl-2 facilitates and maintains the replenishment of Ca2+ in intracellular stores and, as a result, influences the intracellular calcium, thus protecting the cells from death. In addition, there were no cytochrome c release from mitochondria into the cytosol in TG- and Br-A23187- induced apoptosis, suggesting that cytochrome c release is not a universal phenomenon in the apoptotic process.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis*
  • Calcimycin / pharmacology
  • Calcium / deficiency
  • Calcium / metabolism*
  • Caspase 2
  • Caspases / metabolism
  • Cytochrome c Group / metabolism
  • Cytosol / drug effects
  • Cytosol / metabolism
  • DNA Fragmentation / drug effects
  • Egtazic Acid / pharmacology
  • Flow Cytometry
  • Genes, bcl-2 / physiology
  • HL-60 Cells / drug effects
  • HL-60 Cells / metabolism*
  • Humans
  • In Situ Nick-End Labeling
  • Ionophores / pharmacology
  • Membrane Proteins / genetics
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis
  • Proto-Oncogene Proteins c-bcl-2 / physiology*
  • Thapsigargin / pharmacology
  • Transfection

Substances

  • Cytochrome c Group
  • Ionophores
  • Membrane Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Calcimycin
  • Egtazic Acid
  • Thapsigargin
  • Caspase 2
  • Caspases
  • Calcium